期刊文献+

国家谈判药品落地青岛、珠海和成都的待遇水平分析 被引量:1

Analysis on the Benefit Discrepancy of National Negotiated Drugs in Qingdao, Zhuhai and Chengdu
原文传递
导出
摘要 以青岛、珠海、成都3个已建立成熟地方谈判机制的城市为代表,选取原先在其地方谈判药品目录内后被纳入国家医保谈判的品种,对该品种在国家医保谈判前后,患者自付费用变化情况进行分析。结果发现,地方与国家医保谈判相同的品种,经国家医保谈判纳入基本医疗保险报销后,城镇职工的自付费用进一步下降,城乡居民的自付费用不降反增。据此结果,提出了相应的政策建议。 s Qingdao, Zhuhai and Chengdu, which have established local negotiation mechanism, were selected as the to analyze the changes of patients * self^payment before and after the national health insurance negotiation. It found that the self^paid expenses of urban employees were further decreased, and the self-paid expenses of urban and rural residents were increased after the national health insurance negotiations were incorporated into the reimbursement of basic health insurance. Policy suggestions were proposed according to these situation.
作者 吴玉霞 徐伟 WU Yu-xia;XU wei(China Pharmaceutical University, Nanjing, 211198, China)
机构地区 中国药科大学
出处 《中国卫生经济》 北大核心 2019年第10期38-40,共3页 Chinese Health Economics
关键词 药品 国家谈判药品 青岛 珠海 成都 drug National Negotiation drugs Qingdao, Zhuhai Chengdu
  • 相关文献

参考文献1

共引文献6

同被引文献5

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部